What Is Otezla? Uses, Dosage, and What You Need to Know in 2026

If your doctor has recommended Otezla, or you're researching treatment options for plaque psoriasis or psoriatic arthritis, this guide covers everything you need to know. Otezla (generic name: apremilast) is an oral prescription medication — a pill you swallow — that reduces inflammation associated with specific immune-driven skin and joint conditions. It's been on the market since 2014 and has been used by over 650,000 patients worldwide.

What Is Otezla Used For?

Otezla is FDA-approved for three conditions:

Plaque psoriasis: In adults who are candidates for phototherapy or systemic therapy. Also approved for children ages 6 and older weighing at least 20 kg (about 44 lbs) for moderate-to-severe plaque psoriasis. As of 2021, this includes adults with mild plaque psoriasis, making Otezla the first oral systemic treatment approved across all psoriasis severities.

Psoriatic arthritis (PsA): Active psoriatic arthritis in adults and pediatric patients ages 6 and older weighing at least 20 kg. Psoriatic arthritis causes joint pain, swelling, and stiffness in people who have or have had psoriasis.

Oral ulcers associated with Behçet's disease: Adults with painful mouth sores (oral ulcers) caused by Behçet's disease, a rare inflammatory disorder. Approved in 2019.

Otezla is also used off-label by some physicians for other dermatologic conditions that don't respond to conventional therapy.

What Drug Class Is Otezla In?

Otezla belongs to a class of medications called phosphodiesterase 4 (PDE4) inhibitors. It's the first PDE4 inhibitor approved specifically for plaque psoriasis and psoriatic arthritis. Unlike biologics (which are injectable and target specific proteins in the immune system), Otezla is an oral small-molecule medication that works inside cells to modulate inflammation. This means no injections, no needles, and no requirement for routine blood test monitoring.

Otezla Dosage: How to Take It

Otezla comes in two formulations:

Otezla (immediate-release): Available as 10 mg, 20 mg, and 30 mg tablets. The maintenance dose is 30 mg taken twice daily — once in the morning and once in the evening, approximately 12 hours apart.

Otezla XR (extended-release): Available as a 75 mg extended-release tablet taken once daily. Some patients may find once-daily dosing more convenient.

Treatment always starts with a 5-day titration schedule to reduce the risk of GI side effects:

Day 1: 10 mg in the morning only

Day 2: 10 mg twice daily (morning and evening)

Day 3: 10 mg morning + 20 mg evening

Day 4: 20 mg twice daily

Day 5: 20 mg morning + 30 mg evening

Day 6 and on: 30 mg twice daily (maintenance dose)

Your first Otezla prescription will typically include a starter pack with all the tablets needed for the 5-day titration. Swallow tablets whole — do not crush, split, or chew them. You can take Otezla with or without food; eating with food may help reduce nausea.

Who Should Not Take Otezla?

Otezla is contraindicated (should not be used) in patients with a known allergy to apremilast or any ingredient in the formulation. It should be used with caution in pregnancy — animal studies suggest potential risk of fetal loss. Pregnant patients and those planning to become pregnant should discuss the risks with their doctor. There is a pregnancy exposure registry (1-877-311-8972) for patients who become pregnant while taking Otezla.

Dose reduction to 30 mg once daily is required for patients with severe kidney impairment (creatinine clearance less than 30 mL/min). No dose adjustment is needed for liver disease.

How Long Does Otezla Take to Work?

Some patients notice early improvement within the first few weeks of treatment. However, the full clinical benefit of Otezla typically develops over 12 to 16 weeks of continued use. This means it's important not to give up on the medication prematurely due to the GI side effects that may occur in the first 2 weeks — these typically resolve and the medication's benefits continue to build.

What Does Otezla Cost in 2026?

The list price for Otezla is approximately $5,000 to $6,800 per month for a 30-day supply — one of the more expensive oral specialty medications available. No US generic is available until approximately 2028-2029. However, most patients with commercial insurance can reduce their out-of-pocket cost significantly through Amgen's copay assistance program (as little as $0 per fill). Uninsured or underinsured patients with limited income may qualify for free medication through the Amgen Safety Net Foundation. Call Amgen SupportPlus at 1-833-442-6436 to explore options.

Getting Your Otezla Prescription Filled

Otezla is not available at regular retail pharmacies — it must be filled at a specialty pharmacy. medfinder can help you find which pharmacies can fill your prescription by contacting them on your behalf. Read our step-by-step guide: How to Find Otezla in Stock Near You.